Minerva Neurosciences, Inc. (NERV) Dividend History
Income profile from 2012 to 2025 with payout safety and yield-on-cost trend
NERV Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
NERV Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). NERV's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.
NERV Dividend History
No dividend payment history available
Get NERV's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
Minerva Neurosciences, Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 2/9 — weak financial health.
Growth Track Record
NERV does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, NERV returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -81.0%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $556 today.
NERV Dividend vs Peers
Comparable companies in the same industry
NERV Annual Dividend History (2012–2025)
14 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $-34.67 | — | — | — |
| 2024 | $0.00 | — | 0 | $0.19 | — | — | — |
| 2023 | $0.00 | — | 0 | $-4.61 | — | — | — |
| 2022 | $0.00 | — | 0 | $-6.01 | — | — | — |
| 2021 | $0.00 | — | 0 | $-9.35 | — | — | — |
| 2020 | $0.00 | — | 0 | $0.38 | — | — | — |
| 2019 | $0.00 | — | 0 | $-14.80 | — | — | — |
| 2018 | $0.00 | — | 0 | $-10.35 | — | — | — |
| 2017 | $0.00 | — | 0 | $-6.65 | — | — | — |
| 2016 | $0.00 | — | 0 | $-7.88 | — | — | — |
What if you invested $1,000 in NERV back in 2012?
Total return with dividends reinvested · 14+ years of data
Calculate ReturnsHow much would $100/month in NERV be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs NERV Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationNERV vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowNERV — Frequently Asked Questions
Quick answers to the most common questions about buying NERV stock.
How much dividend does NERV pay per share?
Minerva Neurosciences, Inc. (NERV) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is NERV's next ex-dividend date?
NERV's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. NERV typically pays dividends quarterly.
Is NERV's dividend safe?
NERV's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has NERV increased its dividend?
NERV has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does NERV pay dividends?
Minerva Neurosciences, Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 13+ years from 2012 to 2025.
How much would $10,000 invested in NERV grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in NERV five years ago would be worth approximately $1,905 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is NERV's yield on cost for long-term holders?
NERV's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.